Novelix Pharmaceuticals, Inc.

Organization

Pasadena, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
(Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal...
- Patent number 8,058,437
- Issue date Nov 15, 2011
- Novelix Pharmaceuticals, Inc.
- Victor J Bauer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting tumor growth
- Patent number 7,851,462
- Issue date Dec 14, 2010
- Novelix Pharmaceuticals, Inc.
- Edgar Selzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting tumor growth
- Patent number 7,312,205
- Issue date Dec 25, 2007
- Novelix Pharmaceuticals, Inc.
- Edgar Selzer
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKER...
- Publication number 20150306110
- Publication date Oct 29, 2015
- Novelix Pharmaceuticals, Inc.
- Burkhard Jansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKER...
- Publication number 20110077297
- Publication date Mar 31, 2011
- Novelix Pharmaceuticals, Inc.
- Burkhard Jansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL (PYRROLOQUINOXALINYL) PYRAZINECARBOHYDRAZIDE-OXALIC ACID CO-C...
- Publication number 20110034473
- Publication date Feb 10, 2011
- Novelix Pharmaceuticals, Inc.
- Victor J. Bauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING TUMOR GROWTH
- Publication number 20080214516
- Publication date Sep 4, 2008
- Novelix Pharmaceuticals, Inc.
- Edgar Selzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Betulin, betulin derivatives, betulinic acid and betulinic acid der...
- Publication number 20060252733
- Publication date Nov 9, 2006
- Novelix Pharmaceuticals, Inc.
- Burkhard Jansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Medicament for inhibiting tumour growth
- Publication number 20060194774
- Publication date Aug 31, 2006
- Novelix Pharmaceuticals, Inc.
- Edgar Selzer
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
77134840 - DIRECTED SYNERGY
- Serial number 77134840
- Filing date Mar 19, 2007
- Novelix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78612445 - NOVELIX PHARMACEUTICALS
- Serial number 78612445
- Registration number 3294902
- Filing date Apr 20, 2005
- Novelix Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
78612446 - NOVELIX PHARMACEUTICALS
- Serial number 78612446
- Filing date Apr 20, 2005
- Novelix Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 1

Research Projects

Information Research Project
Directed Synergy: A New Strategy to Combine Targeted Therapeutics
- Application id 7405829
- Award notice date Sep 27, 2007

Novelix Pharmaceuticals, Inc.

Organization

Patents Grantslast 30 patents

(Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal...

Methods and compositions for inhibiting tumor growth

Methods and compositions for inhibiting tumor growth

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKER...

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKER...

NOVEL (PYRROLOQUINOXALINYL) PYRAZINECARBOHYDRAZIDE-OXALIC ACID CO-C...

METHODS AND COMPOSITIONS FOR INHIBITING TUMOR GROWTH

Betulin, betulin derivatives, betulinic acid and betulinic acid der...

Medicament for inhibiting tumour growth

Trademarklast 30 trademarks

77134840 - DIRECTED SYNERGY

78612445 - NOVELIX PHARMACEUTICALS

78612446 - NOVELIX PHARMACEUTICALS

NIH Research Projectlast 12 months

Research Projects

Directed Synergy: A New Strategy to Combine Targeted Therapeutics